Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bolt Biotherapeutics Inc
(NQ:
BOLT
)
0.7533
-0.0117 (-1.53%)
Streaming Delayed Price
Updated: 10:47 AM EDT, May 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bolt Biotherapeutics Inc
< Previous
1
2
3
Next >
Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2023
May 12, 2023
Via
Benzinga
Bolt Biotherapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
May 11, 2023
From
Bolt Biotherapeutics, Inc.
Via
GlobeNewswire
Bolt Biotherapeutics to Present Clinical Data from Phase 1 Dose-Escalation Trial of BDC-1001 in HER2-Expressing Tumors at 2023 ASCO Annual Meeting
April 26, 2023
Comprehensive Phase 1 data at ASCO support initiation of two Phase 2 trials
From
Bolt Biotherapeutics, Inc.
Via
GlobeNewswire
Looking Into Bolt Biotherapeutics's Return On Capital Employed
March 30, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
April 08, 2022
During Friday's morning session, 234 stocks hit new 52-week lows. Interesting Facts About Today's 52-Week Lows: The largest company in terms of market cap...
Via
Benzinga
Bolt Biotherapeutics Says Phase 1 Data Supports Advancing Into Phase 2 Studies
March 30, 2023
Via
Benzinga
Bolt Biotherapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 29, 2023
From
Bolt Biotherapeutics, Inc.
Via
GlobeNewswire
Bolt Biotherapeutics Announces Positive Topline Data from BDC-1001 Phase 1 Dose-Escalation Trial in HER2-Expressing Tumors, Supporting Advancement to Phase 2 Clinical Studies
March 29, 2023
From
Bolt Biotherapeutics, Inc.
Via
GlobeNewswire
Bolt Biotherapeutics to Present Preclinical Data for BDC-3042, a Dectin-2-Targeting Agonistic Antibody, at 2023 AACR Annual Meeting
March 14, 2023
From
Bolt Biotherapeutics, Inc.
Via
GlobeNewswire
Bolt Biotherapeutics to Present at Cowen 43rd Annual Healthcare Conference
February 28, 2023
From
Bolt Biotherapeutics, Inc.
Via
GlobeNewswire
Bolt Biotherapeutics to Present at February Investor Conferences
February 01, 2023
From
Bolt Biotherapeutics, Inc.
Via
GlobeNewswire
Bolt Biotherapeutics Appoints Laura Berner to Board of Directors
December 14, 2022
From
Bolt Biotherapeutics, Inc.
Via
GlobeNewswire
Bolt Biotherapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
November 10, 2022
From
Bolt Biotherapeutics, Inc.
Via
GlobeNewswire
Bolt Biotherapeutics to Present Preclinical Data on BDC-3042, Dectin-2 Targeting Agonistic Antibody, at the SITC Annual Meeting
November 07, 2022
From
Bolt Biotherapeutics, Inc.
Via
GlobeNewswire
Bolt Biotherapeutics to Present at Stifel 2022 Healthcare Conference
November 01, 2022
From
Bolt Biotherapeutics, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2022
August 11, 2022
Via
Benzinga
SVB Leerink Cuts Price Target On This Stock By 50%, Also Check Out Some Other Major PT Changes
August 11, 2022
SVB Leerink cut the price target on Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) from $8 to $4. SVB Leerink analyst Daina Graybosch downgraded the stock from Outperform to Market Perform. Bolt...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 20, 2022
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares increased by 15.1% to $0.63 during Wednesday's after-market session. The company's market cap stands at $16.7 million.
Via
Benzinga
This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday
July 08, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 07, 2022
Via
Benzinga
Bolt Biotherapeutics's Return On Capital Employed Overview
March 31, 2022
Bolt Biotherapeutics (NASDAQ:BOLT) brought in sales totaling $508.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 16.08%, resulting in a loss of $27.16...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 28, 2022
Gainers Soleno Therapeutics (NASDAQ:SLNO) shares rose 15.7% to $0.37 during Monday's pre-market session. The market value of their outstanding shares is at $29.5...
Via
Benzinga
7 Little-Known Penny Stocks That Could Take Off Any Moment
January 27, 2022
Penny stocks are incredibly risky and should only be considered with speculation funds. Still, these names could swing higher for investors.
Via
InvestorPlace
Mid-Afternoon Market Update: Dow Jumps 700 Points; Del Taco Restaurants Shares Spike Higher
December 06, 2021
Toward the end of trading Monday, the Dow traded up 2.11% to 35,308.84 while the NASDAQ rose 1.24% to 15,272.25. The S&P also rose, gaining 1.51% to 4,607.08. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2022
January 06, 2022
Upgrades For Canada Goose Holdings Inc (NYSE:
Via
Benzinga
60 Biggest Movers From Yesterday
December 07, 2021
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 200.4% to close at $15.05 on Monday after the company announced the commencement of a formal process to explore...
Via
Benzinga
Mid-Day Market Update: Crude Oil Rises 3%; Aeglea BioTherapeutics Shares Plunge
December 06, 2021
Midway through trading Monday, the Dow traded up 1.94% to 35,251.31 while the NASDAQ rose 0.55% to 15,168.35. The S&P also rose, gaining 1.20% to 4,592.83. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
36 Stocks Moving In Monday's Mid-Day Session
December 06, 2021
Gainers Del Taco Restaurants, Inc. (NASDAQ: TACO) shares jumped 64.6% to $12.40. Jack In The Box Inc (NASDAQ: JACK) agreed to acquire Del Taco Restaurants for $12.51 per share...
Via
Benzinga
Dow Extends Rebound as Omicron Fears Subside
December 06, 2021
The Dow Jones Industrial Average is gaining even more momentum off this morning's bounce, the S&P 500 is also eyeing a strong rally. The Nasdaq Composite (IXIC), on the other hand, has turned...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.